Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5565242 | Complementary Therapies in Medicine | 2017 | 11 Pages |
Abstract
The available evidence from present study supported but limited to recommend the routine use of CHM adjuvant therapy for MS because of the poor methodological quality and clinical heterogeneity. However, we identified an area that is worthy of further study. Furthermore, we selected high frequent use of CHMs as a promising candidate for further clinical application and MS trials. Further rigorous randomized-controlled trials are needed.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Complementary and Alternative Medicine
Authors
Liang Song, Qi-hui Zhou, Hui-lin Wang, Feng-jiao Liao, Liang Hua, Hong-feng Zhang, Li-bo Huang, Yan Lin, Guo-qing Zheng,